Ryan Kaple
- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Cardiac Imaging and Diagnostics
- Cardiac pacing and defibrillation studies
- Cardiovascular Function and Risk Factors
- Aortic Disease and Treatment Approaches
- Cardiac Structural Anomalies and Repair
- Cardiac Arrhythmias and Treatments
- Coronary Interventions and Diagnostics
- Cardiac, Anesthesia and Surgical Outcomes
- Mechanical Circulatory Support Devices
- Pulmonary Hypertension Research and Treatments
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Cerebrovascular and Carotid Artery Diseases
- Cardiomyopathy and Myosin Studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Congenital Heart Disease Studies
- Cardiac and Coronary Surgery Techniques
- Cardiovascular Disease and Adiposity
- Peripheral Artery Disease Management
- Aortic aneurysm repair treatments
- Venous Thromboembolism Diagnosis and Management
- Health Systems, Economic Evaluations, Quality of Life
- Renal Transplantation Outcomes and Treatments
Hackensack University Medical Center
2022-2024
Yale University
2007-2023
Jersey Shore University Medical Center
2023
Yale New Haven Hospital
2020-2022
Westchester Medical Center
2016-2021
Mount Sinai Health System
2018-2020
Rigshospitalet
2020
Brigham and Women's Hospital
2020
Mount Sinai Medical Center
2019
New York Hospital Queens
2013-2016
Tricuspid regurgitation (TR) has a poor prognosis and limited treatment options is frequently accompanied by right ventricular (RV) dysfunction. Transcatheter tricuspid valve interventions (TTVI) to reduce TR have been shown be safe feasible with encouraging early results. Patient selection for TTVI remains challenging, the role of function being unknown.The aims this study were 1) investigate survival in TTVI-treated patient population conservatively treated population, 2) evaluate outcome...
Scarce data exist on patients with right ventricular dysfunction (RVD) or pulmonary hypertension (PH) undergoing transcatheter tricuspid valve intervention. This study aimed to determine the early and midterm outcomes factors associated mortality in this group of patients. subanalysis multicenter TriValve (Transcatheter Tricuspid Valve Therapies) registry included 300 severe regurgitation RVD (n=244), PH (n=127), both (n=71) was defined as a annular plane systolic excursion <17 mm, an...
Purpose To establish an ex vivo experimental setup for imaging coronary atherosclerosis with computed tomographic (CT) angiography, intravascular ultrasonography (US), and optical frequency domain (OFDI) to investigate their ability help differentiate early from advanced plaques. Materials Methods All procedures were performed in accordance local federal regulations the Declaration of Helsinki. Approval Ethics Committee was obtained. Overall, 379 histologic cuts nine arteries three donor...